A new HRT pill that could prevent breast cancer has been hailed as a breakthrough with the potential to help millions of women. Scientists said the treatment was “the great hope” for women around the world, because current drugs taken by those approaching the menopause have been repeatedly linked with a higher risk of the disease. Prof Richard Santen, from the University of Virginia, was part of the team that developed the drug. He said: “If this does what we think it does, this is huge.”